ABN AMRO INVESTMENT SOLUTIONS
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 2080520
PARIS CEDEX 008, I0
Position in ALNY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,274,883
+$366,756 QoQ
Shares Held
7,557
+31.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#317
of 784 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ABN AMRO INVESTMENT SOLUTIONS holds $84,184,851 across 9 Biotechnology names. ALNY ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
84,631 | $42,038,756 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
65,524 | $18,672,374 | |
| 3 | ARGX |
Argenx SE
|
9,902 | $9,186,778 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,114 | $3,812,323 | |
| 5 | RPRX |
Royalty Pharma plc
|
63,500 | $3,560,444 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
7,557 | $2,274,883 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
11,990 | $2,245,487 | |
| 8 | INSM |
INSMED Inc
|
12,028 | $1,282,425 |
All Filings in ALNY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,274,883 | 7,557 | Shares | Other | 2026-07-23 | |
| 2026-03-31 | $1,908,127 | 5,767 | Shares | Other | 2026-05-12 | |
| 2025-12-31 | $2,290,066 | 5,759 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $597,360 | 1,310 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $427,177 | 1,310 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $353,726 | 1,310 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $284,960 | 1,211 | Shares | Defined | 2025-09-04 | |
| 2024-09-30 | $383,391 | 1,394 | Shares | Defined | 2025-09-04 | |
| No filing history on record for this holder in this stock. | ||||||